Physician profile
Stephen P Cassis
NPI 1093709289
$7,880.27
in general payments reported to CMS, 2019-2025
17 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $28.70 · 2021: $206 · 2022: $133 · 2023: $5,796 · 2024: $464 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,378 · Food and Beverage: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,378.06 |
| Food and Beverage | $1,338.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $6,283.53 | 2019-2025 | Clareon, Clareon Panoptix Pro, Simbrinza |
| Johnson & Johnson Surgical Vision, INC. | $243.25 | 2019-2025 | Veritas Vision System, Sovereign Compact, Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $163.77 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Amgen INC. | $124.99 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Ani Pharmaceuticals, INC. | $120.36 | 2025 | Purified Cortrophin Gel |
| Aerie Pharmaceuticals, INC. | $119.58 | 2019 | |
| Sun Pharmaceutical Industries INC. | $113.19 | 2019 | |
| Oyster Point Pharma, INC. | $110.27 | 2022 | |
| Allergan, INC. | $101.97 | 2019 | |
| Omeros Corporation | $99.98 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.73 | 2019 | |
| Abbvie INC. | $60.19 | 2024-2025 | |
| Vantage Technology LLC | $49.37 | 2019-2020 | |
| Medtronic, INC. | $36.21 | 2024 | Closurefast |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $22.53 | 2019 | |
| Glaukos Corporation | $17.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cassis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.